Tectonic Therapeutic, Inc. also files under AVRO; those filings are included.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | McNamara Peter | Chief Scientific Officer | Grant(A) | 21K | — | $0 |
| Sep 3, 2026 | Reicin Alise | Chief Executive Officer, Director | Grant(A) | 69K | — | $0 |
| Sep 3, 2026 | Schwabish Marc | Chief Business Officer | Grant(A) | 18K | — | $0 |
| Sep 3, 2026 | Lochner Daniel | Chief Financial Officer | Grant(A) | 24K | — | $0 |
| Sep 3, 2026 | Ruddy Marcella K. | Chief Medical Officer | Grant(A) | 24K | — | $0 |
| Aug 25, 2026 | McNamara Peter | Chief Scientific Officer | Option exercise(M) | 43 | — | $0 |
| Aug 25, 2026 | McNamara Peter | Chief Scientific Officer | Sell(S) | 43 | $36.52 | $2K |
| Aug 25, 2026 | McNamara Peter | Chief Scientific Officer | Option exercise(M) | 43 | $14.71 | $633 |
| Aug 12, 2026 | McNamara Peter | Chief Scientific Officer | Option exercise(M) | 43 | $14.71 | $633 |
| Aug 12, 2026 | McNamara Peter | Chief Scientific Officer | Sell(S) | 43 | $35.00 | $2K |
| Aug 12, 2026 | McNamara Peter | Chief Scientific Officer | Option exercise(M) | 43 | — | $0 |
| Jun 30, 2026 | McNamara Peter | Chief Scientific Officer | Sell(S) | 172 | $35.00 | $6K |
| Jun 30, 2026 | McNamara Peter | Chief Scientific Officer | Option exercise(M) | 172 | — | $0 |
| Jun 30, 2026 | McNamara Peter | Chief Scientific Officer | Option exercise(M) | 172 | $14.71 | $3K |
| Jun 20, 2026 | Reicin Alise | Chief Executive Officer, Director | Tax withholding(F) | 924 | $30.34 | $28K |
| Jun 11, 2026 | Lochner Daniel | Chief Financial Officer | Grant(A) | 8K | — | $0 |
| Jun 9, 2026 | Tipirneni Praveen P. | Director | Grant(A) | 10K | — | $0 |
| Jun 9, 2026 | Donenberg Phillip B. | Director | Grant(A) | 10K | — | $0 |
| Jun 9, 2026 | Vitorovic Stefan | Director | Grant(A) | 10K | — | $0 |
| Jun 9, 2026 | Springer Timothy A | Director, 10% Owner | Grant(A) | 10K | — | $0 |
| Jun 8, 2026 | Chutter Jessica Caroline | Director | Grant(A) | 20K | — | $0 |
| May 4, 2026 | Ruddy Marcella K. | Chief Medical Officer | Sell(S) | 1K | $30.00 | $32K |
| Apr 1, 2026 | Ruddy Marcella K. | Chief Medical Officer | Sell(S) | 1K | $31.05 | $31K |
| Apr 1, 2026 | Nader Francois | Director | Grant(A) | 20K | — | $0 |
| Mar 6, 2026 | McNamara Peter | Chief Scientific Officer | Option exercise(M) | 215 | — | $0 |
| Mar 6, 2026 | McNamara Peter | Chief Scientific Officer | Option exercise(M) | 3K | $2.38 | $6K |
| Mar 6, 2026 | McNamara Peter | Chief Scientific Officer | Sell(S) | 6K | $30.00 | $181K |
| Mar 6, 2026 | McNamara Peter | Chief Scientific Officer | Option exercise(M) | 215 | $14.71 | $3K |
| Mar 6, 2026 | McNamara Peter | Chief Scientific Officer | Sell(S) | 215 | $35.00 | $8K |
| Mar 6, 2026 | McNamara Peter | Chief Scientific Officer | Option exercise(M) | 3K | — | — |
| Mar 6, 2026 | Ruddy Marcella K. | Chief Medical Officer | Sell(S) | 10K | $30.00 | $300K |
| Mar 4, 2026 | Lochner Daniel | Chief Financial Officer | Grant(A) | 24K | — | $0 |
| Mar 4, 2026 | Lochner Daniel | Chief Financial Officer | Grant(A) | 27K | — | $0 |
| Mar 4, 2026 | McNamara Peter | Chief Scientific Officer | Grant(A) | 21K | — | $0 |
| Mar 4, 2026 | McNamara Peter | Chief Scientific Officer | Grant(A) | 23K | — | $0 |
| Mar 4, 2026 | McNamara Peter | Chief Scientific Officer | Sell(S) | 2K | $25.00 | $41K |
| Mar 4, 2026 | Reicin Alise | Chief Executive Officer, Director | Grant(A) | 69K | — | $0 |
| Mar 4, 2026 | Schwabish Marc | Chief Business Officer | Grant(A) | 18K | — | $0 |
| Mar 4, 2026 | Reicin Alise | Chief Executive Officer, Director | Grant(A) | 77K | — | $0 |
| Mar 4, 2026 | Schwabish Marc | Chief Business Officer | Grant(A) | 20K | — | $0 |
| Mar 4, 2026 | Ruddy Marcella K. | Chief Medical Officer | Grant(A) | 24K | — | $0 |
| Mar 4, 2026 | Ruddy Marcella K. | Chief Medical Officer | Grant(A) | 27K | — | $0 |
| Mar 3, 2026 | McNamara Peter | Chief Scientific Officer | Sell(S) | 2K | $22.06 | $36K |
| Feb 11, 2026 | Reicin Alise | Chief Executive Officer, Director | Buy(P) | 3K | $21.10 | $53K |
| Feb 10, 2026 | Lochner Daniel | Chief Financial Officer | Buy(P) | 6K | $21.61 | $130K |
| Feb 10, 2026 | Schwabish Marc | Chief Business Officer | Option exercise(M) | 5K | — | — |
| Feb 10, 2026 | Schwabish Marc | Chief Business Officer | Option exercise(M) | 5K | $2.38 | $11K |
| Feb 4, 2026 | Lochner Daniel | Chief Financial Officer | Tax withholding(F) | 2K | $23.22 | $48K |
| Feb 4, 2026 | McNamara Peter | Chief Scientific Officer | Tax withholding(F) | 2K | $23.22 | $41K |
| Feb 4, 2026 | Reicin Alise | Chief Executive Officer, Director | Tax withholding(F) | 4K | $23.22 | $95K |
| Feb 4, 2026 | Schwabish Marc | Chief Business Officer | Tax withholding(F) | 2K | $23.22 | $38K |
| Feb 4, 2026 | Ruddy Marcella K. | Chief Medical Officer | Tax withholding(F) | 2K | $23.22 | $48K |
| Dec 31, 2025 | Reicin Alise | Chief Executive Officer, Director | Option exercise(M) | 11K | — | — |
| Dec 31, 2025 | Reicin Alise | Chief Executive Officer, Director | Option exercise(M) | 11K | $2.38 | $26K |
| Dec 22, 2025 | McNamara Peter | Chief Scientific Officer | Option exercise(M) | 7K | — | — |
| Dec 22, 2025 | McNamara Peter | Chief Scientific Officer | Option exercise(M) | 7K | $2.98 | $21K |
| Sep 25, 2025 | Reicin Alise | Chief Executive Officer, Director | Grant(A) | 15K | — | $0 |
| Sep 25, 2025 | Ruddy Marcella K. | Chief Medical Officer | Grant(A) | 10K | — | $0 |
| Sep 25, 2025 | Ruddy Marcella K. | Chief Medical Officer | Grant(A) | 5K | — | $0 |
| Sep 25, 2025 | McNamara Peter | Chief Scientific Officer | Grant(A) | 8K | — | $0 |
| Sep 25, 2025 | McNamara Peter | Chief Scientific Officer | Grant(A) | 5K | — | $0 |
| Sep 25, 2025 | Schwabish Marc | Chief Business Officer | Grant(A) | 8K | — | $0 |
| Sep 25, 2025 | Schwabish Marc | Chief Business Officer | Grant(A) | 4K | — | $0 |
| Sep 25, 2025 | Lochner Daniel | Chief Financial Officer | Grant(A) | 5K | — | $0 |
| Sep 25, 2025 | Lochner Daniel | Chief Financial Officer | Grant(A) | 10K | — | $0 |
| Sep 25, 2025 | Reicin Alise | Chief Executive Officer, Director | Grant(A) | 27K | — | $0 |
| Jun 20, 2025 | Reicin Alise | Chief Executive Officer, Director | Tax withholding(F) | 859 | $19.81 | $17K |
| Jun 9, 2025 | Donenberg Phillip B. | Director | Grant(A) | 10K | — | $0 |
| Jun 9, 2025 | Vitorovic Stefan | Director | Grant(A) | 10K | — | $0 |
| Jun 9, 2025 | McGuire Terrance | Director | Grant(A) | 10K | — | $0 |
| Jun 9, 2025 | Tipirneni Praveen P. | Director | Grant(A) | 10K | — | $0 |
| Jun 9, 2025 | Springer Timothy A | Director, 10% Owner | Grant(A) | 10K | — | $0 |
| Apr 11, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 9K | $16.31 | $155K |
| Apr 11, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 54K | $16.31 | $876K |
| Apr 10, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 46K | $16.73 | $767K |
| Apr 10, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 8K | $16.73 | $135K |
| Apr 9, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 16K | $14.62 | $237K |
| Apr 9, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 5K | $15.23 | $74K |
| Apr 9, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 857 | $15.23 | $13K |
| Apr 9, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 3K | $14.62 | $42K |
| Apr 7, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 88K | $17.10 | $1.5M |
| Apr 7, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 413K | $17.10 | $7.1M |
| Apr 7, 2025 | McGuire Terrance | Director | Sell(S) | 500K | $17.10 | $8.6M |
| Feb 5, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 660K | $50.00 | $33.0M |
| Feb 5, 2025 | Springer Timothy A | Director, 10% Owner | Buy(P) | 129K | $54.14 | $7.0M |
| Feb 5, 2025 | Lochner Daniel | Chief Financial Officer | Buy(P) | 5K | $54.14 | $250K |
| Feb 4, 2025 | Schwabish Marc | Chief Business Officer | Grant(A) | 25K | — | $0 |
| Feb 4, 2025 | Schwabish Marc | Chief Business Officer | Grant(A) | 14K | — | $0 |
| Feb 4, 2025 | McNamara Peter | Chief Scientific Officer | Grant(A) | 28K | — | $0 |
| Feb 4, 2025 | McNamara Peter | Chief Scientific Officer | Grant(A) | 15K | — | $0 |
| Feb 4, 2025 | Lochner Daniel | Chief Financial Officer | Grant(A) | 33K | — | $0 |
| Feb 4, 2025 | Lochner Daniel | Chief Financial Officer | Grant(A) | 18K | — | $0 |
| Feb 4, 2025 | Ruddy Marcella K. | Chief Medical Officer | Grant(A) | 33K | — | $0 |
| Feb 4, 2025 | Ruddy Marcella K. | Chief Medical Officer | Grant(A) | 18K | — | $0 |
| Feb 4, 2025 | Reicin Alise | Chief Executive Officer, Director | Grant(A) | 102K | — | $0 |
| Feb 4, 2025 | Reicin Alise | Chief Executive Officer, Director | Grant(A) | 36K | — | $0 |
| Jan 28, 2025 | Schwabish Marc | Chief Business Officer | Option exercise(M) | 3K | — | — |
| Jan 28, 2025 | Schwabish Marc | Chief Business Officer | Option exercise(M) | 3K | $2.38 | $6K |
| Dec 9, 2024 | Schwabish Marc | Chief Business Officer | Option exercise(M) | 2K | — | — |
| Dec 9, 2024 | Schwabish Marc | Chief Business Officer | Option exercise(M) | 2K | $2.38 | $5K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Tectonic Therapeutic, Inc., SEC CIK 0001681087. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under TECX and shows every filing by that issuer (also filed as AVRO).
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-19. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for TECX